Pharma Reviews: Sun Pharma posts Q2 loss at ₹219 crore on one-time charge

Indian pharmaceutical companies have been hit by US regulatory bans and warnings over quality control violations at production plants, which have ...
Read more: Sun Pharma posts Q2 loss at ₹219 crore on one-time charge